Abstract：
Headache affects around half of patients in the acute phase of COVID-19 and generally occurs at the beginning of the symptomatic phase, has an insidious onset, and is bilateral, and of moderate to severe intensity. COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. In 10% to 20% of patients with COVID-19, headache may persist beyond the acute phase. In general, the headache improves over time. To date, there are no clinical trials that have assessed the treatment of persistent post-COVID-19 headache.
摘要：
头痛影响COVID-19急性期约一半的患者，通常发生在症状期开始时，有一个阴险的发作，是双边的，中等至重度强度。COVID-19还可能出现引起急性和持续性头痛的并发症，比如脑血管疾病，鼻窦炎,脑膜炎,颅内高压.在10％至20％的COVID-19患者中，头痛可能持续超过急性期。总的来说,头痛会随着时间的推移而改善。迄今为止,尚无临床试验评估COVID-19后持续性头痛的治疗方法.
